Hourglass Capital, LLC has filed its 13F form on January 30, 2025 for Q4 2024 where it was disclosed a total value porftolio of $361 Million distributed in 105 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Pfizer Inc with a value of $10.6M, Goldman Sachs Group Inc with a value of $10.1M, Morgan Stanley with a value of $9.36M, Citigroup Inc with a value of $8.84M, and Apple Inc. with a value of $8.82M.

Examining the 13F form we can see an increase of $2.74M in the current position value, from $359M to 361M.

Below you can find more details about Hourglass Capital, LLC portfolio as well as his latest detailed transactions.

Portfolio value $361 Million
Energy: $61.7 Million
Technology: $58.1 Million
Financial Services: $55.5 Million
Healthcare: $37.1 Million
Basic Materials: $34.2 Million
Consumer Defensive: $31.9 Million
Industrials: $18.5 Million
Consumer Cyclical: $17.6 Million
Other: $46.7 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 105
  • Current Value $361 Million
  • Prior Value $359 Million
  • Filing
  • Period Q4 2024
  • Filing Date January 30, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 6 stocks
  • Additional Purchases 43 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 27 stocks
Track This Portfolio

Track Hourglass Capital, LLC Portfolio

Follow Hourglass Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hourglass Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hourglass Capital, LLC with notifications on news.